| 1 |
32393046 |
10.1080/09603123.2020.1757043 |
2022 |
The expression of microRNAs and exposure to environmental contaminants related to human health: a review. |
HLA-A |
| 2 |
33648421 |
10.1080/07391102.2021.1889669 |
2022 |
<i>In silico</i> identification of epitope-based vaccine candidates against HTLV-1. |
HLA-A |
| 3 |
34926267 |
10.3389/fonc.2021.765544 |
2022 |
<i>SEPT6</i>_<i>TRIM33</i> Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas. |
HLA-A |
| 4 |
35176142 |
10.1158/2326-6066.CIR-21-0307 |
2022 |
A Costimulatory CAR Improves TCR-based Cancer Immunotherapy. |
HLA-A |
| 5 |
35254876 |
10.1200/JCO.21.01805 |
2022 |
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. |
HLA-A |
| 6 |
35358442 |
10.1016/S2352-3026(22)00036-9 |
2022 |
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. |
HLA-A |
| 7 |
35504960 |
10.1038/s41598-022-11247-z |
2022 |
A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents. |
HLA-A |
| 8 |
35759244 |
10.1002/iid3.666 |
2022 |
EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study. |
HLA-A |
| 9 |
35840432 |
10.1016/j.transproceed.2022.05.005 |
2022 |
Successful Kidney and Hematopoietic Stem Cell Transplantation for Malignant Lymphoma from Different Donors: A Case Report and Literature Review. |
HLA-A |
| 10 |
35845006 |
10.1002/jha2.116 |
2022 |
Genetic aberrations of <i>NLRC5</i> are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma. |
HLA-A |
| 11 |
35953408 |
10.1016/j.humimm.2022.08.002 |
2022 |
HLA homozygosity is associated with Non-Hodgkin lymphoma. |
HLA-A |
| 12 |
36081501 |
10.3389/fimmu.2022.993025 |
2022 |
Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1. |
HLA-A |
| 13 |
28659916 |
10.3389/fimmu.2017.00675 |
2021 |
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy. |
HLA-A |
| 14 |
28811957 |
10.1080/2162402X.2017.1321184 |
2021 |
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma. |
HLA-A |
| 15 |
29147614 |
10.1080/2162402X.2017.1356964 |
2021 |
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy. |
HLA-A |
| 16 |
32072624 |
10.1111/bjh.16398 |
2021 |
Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. |
HLA-A |
| 17 |
32079700 |
10.3324/haematol.2019.236836 |
2021 |
Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma. |
HLA-A |
| 18 |
32311478 |
10.1016/j.bbmt.2020.04.006 |
2021 |
Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia. |
HLA-A |
| 19 |
32883310 |
10.1186/s12977-020-00536-y |
2021 |
HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. |
HLA-A |
| 20 |
32964767 |
10.1080/10428194.2020.1821011 |
2021 |
Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas. |
HLA-A |
| 21 |
32973816 |
10.3389/fimmu.2020.02076 |
2021 |
Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression. |
HLA-A |
| 22 |
33267617 |
10.1177/0963689720976567 |
2021 |
Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin. |
HLA-A |
| 23 |
33410215 |
10.1111/cas.14800 |
2021 |
Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients. |
HLA-A |
| 24 |
34128753 |
10.1080/10428194.2021.1929958 |
2021 |
Combined impact of HLA-allele matching and the CD34-positive cell dose on optimal unit selection for single-unit cord blood transplantation in adults. |
HLA-A |
| 25 |
29204156 |
10.1155/2017/6527306 |
2020 |
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients. |
HLA-A |
| 26 |
30396848 |
10.1016/j.jcyt.2018.08.001 |
2020 |
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy. |
HLA-A |
| 27 |
30715139 |
10.1093/asj/sjz021 |
2020 |
Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. |
HLA-A |
| 28 |
31066027 |
10.1002/cpt.1493 |
2020 |
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions. |
HLA-A |
| 29 |
31092896 |
10.1038/s41375-019-0473-1 |
2020 |
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. |
HLA-A |
| 30 |
31155783 |
10.1111/joim.12911 |
2020 |
The role of HLA variation in lymphoma aetiology and survival. |
HLA-A |
| 31 |
31215275 |
10.1080/10428194.2019.1617858 |
2020 |
The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population. |
HLA-A |
| 32 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
HLA-A |
| 33 |
31958417 |
10.1016/S2352-3026(19)30220-0 |
2020 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. |
HLA-A |
| 34 |
32257153 |
10.7189/jogh.10.010405 |
2020 |
Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence. |
HLA-A |
| 35 |
32808978 |
10.1093/infdis/jiaa512 |
2020 |
Identification of Functional HLA-A*01 :01-Restricted EBV-LMP2-Specific T-cell Receptors. |
HLA-A |
| 36 |
29367710 |
10.1038/s41409-017-0084-2 |
2019 |
The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis. |
HLA-A |
| 37 |
29441070 |
10.3389/fimmu.2018.00099 |
2019 |
A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations. |
HLA-A |
| 38 |
29467338 |
10.1172/jci.insight.97805 |
2019 |
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. |
HLA-A |
| 39 |
29496759 |
10.1158/1078-0432.CCR-17-2483 |
2019 |
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression. |
HLA-A |
| 40 |
29661776 |
10.1158/1078-0432.CCR-17-2626 |
2019 |
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma. |
HLA-A |
| 41 |
30123963 |
10.1111/tan.13379 |
2019 |
Identification of the novel HLA-A*29:113 allele in a Hodgkin's Lymphoma patient. |
HLA-A |
| 42 |
30311452 |
10.1111/tan.13406 |
2019 |
Two novel alleles, HLA-A*32:01:01:09 and 32:01:01:10, identified by Pacific Bioscience's SMRT sequencing. |
HLA-A |
| 43 |
30864683 |
10.3892/ijo.2019.4740 |
2019 |
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation. |
HLA-A |
| 44 |
27090957 |
10.1016/j.bbmt.2016.04.007 |
2018 |
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. |
HLA-A |
| 45 |
27273744 |
10.1111/tan.12829 |
2018 |
The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients. |
HLA-A |
| 46 |
27776339 |
10.18632/oncotarget.12778 |
2018 |
Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies. |
HLA-A |
| 47 |
28126967 |
10.3324/haematol.2016.158584 |
2018 |
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. |
HLA-A |
| 48 |
28677225 |
10.1111/tan.13081 |
2018 |
Identification of a new HLA-A allele, HLA-A*02:07:09, in a Chinese non-Hodgkin lymphoma patient. |
HLA-A |
| 49 |
28948342 |
10.1007/s00403-017-1783-7 |
2018 |
Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients. |
HLA-A |
| 50 |
28981945 |
10.3760/cma.j.issn.1003-9406.2017.05.026 |
2018 |
[Association of HLA-A, -B, -DRB1 alleles and haplotypes with acute lymphoblastic leukemia among ethnic Hans from northern China]. |
HLA-A |
| 51 |
29080718 |
10.1016/j.humimm.2017.10.010 |
2018 |
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies. |
HLA-A |
| 52 |
26537309 |
10.1111/jdv.13462 |
2017 |
Carbamazepine-induced HLA-A*3101 associated hypersensitivity syndrome mimicking mycosis fungoides. |
HLA-A |
| 53 |
26636741 |
10.1097/TP.0000000000001025 |
2017 |
HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation. |
HLA-A |
| 54 |
27007051 |
10.18632/oncotarget.8198 |
2017 |
Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes. |
HLA-A |
| 55 |
27063556 |
10.1016/j.gene.2016.04.017 |
2017 |
The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients. |
HLA-A |
| 56 |
27095065 |
10.4274/tjh.2016.0102 |
2017 |
The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study. |
HLA-A |
| 57 |
27104753 |
10.3109/10428194.2016.1173209 |
2017 |
Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder. |
HLA-A |
| 58 |
27414060 |
10.1111/cei.12842 |
2017 |
Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. |
HLA-A |
| 59 |
28252558 |
10.1097/TP.0000000000001713 |
2017 |
Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation. |
HLA-A |
| 60 |
28334025 |
10.1371/journal.pone.0174457 |
2017 |
HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients. |
HLA-A |
| 61 |
28627735 |
10.1111/cas.13303 |
2017 |
Genetic alterations in adult T-cell leukemia/lymphoma. |
HLA-A |
| 62 |
28724766 |
10.1128/JVI.00974-17 |
2017 |
A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax<sub>301-309</sub>-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients. |
HLA-A |
| 63 |
25648508 |
10.1002/ijc.29467 |
2016 |
Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. |
HLA-A |
| 64 |
25688540 |
10.1002/cyto.a.22643 |
2016 |
A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines. |
HLA-A |
| 65 |
25761323 |
10.2450/2015.0236-14 |
2016 |
Erroneous HLA typing as a result of acquired uniparental disomy in a patient with acute lymphoblastic leukaemia in peripheral blood complete remission. |
HLA-A |
| 66 |
26261988 |
10.1371/journal.pone.0135512 |
2016 |
HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. |
HLA-A |
| 67 |
26334430 |
10.1097/MPH.0000000000000419 |
2016 |
HLA Polymorphism in Algerian Children With Lymphomas. |
HLA-A |
| 68 |
26422112 |
10.1111/cei.12716 |
2016 |
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. |
HLA-A |
| 69 |
27457573 |
10.3109/10428199109064876 |
2016 |
Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype. |
HLA-A |
| 70 |
27467957 |
10.1080/2162402X.2016.1138199 |
2016 |
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA. |
HLA-A |
| 71 |
24533560 |
10.1111/jdv.12391 |
2015 |
Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients. |
HLA-A |
| 72 |
24681846 |
10.1371/journal.pone.0093321 |
2015 |
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer. |
HLA-A |
| 73 |
24963477 |
10.1155/2014/231236 |
2015 |
The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients. |
HLA-A |
| 74 |
25402415 |
10.1038/bmt.2014.259 |
2015 |
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. |
HLA-A |
| 75 |
25414443 |
10.1182/blood-2014-07-587840 |
2015 |
Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b. |
HLA-A |
| 76 |
25549594 |
IJIv11i4A5 |
2015 |
HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma. |
HLA-A |
| 77 |
25731678 |
10.1016/j.trim.2015.02.005 |
2015 |
HLA class I associations with EBV+ post-transplant lymphoproliferative disorder. |
HLA-A |
| 78 |
23376818 |
10.1038/bmt.2013.4 |
2014 |
The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis. |
HLA-A |
| 79 |
23508008 |
10.3324/haematol.2012.071340 |
2014 |
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells. |
HLA-A |
| 80 |
23608951 |
10.1007/s10384-013-0244-x |
2014 |
Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. |
HLA-A |
| 81 |
23812418 |
10.1038/leu.2013.196 |
2014 |
Functional characterization of Foxp3-specific spontaneous immune responses. |
HLA-A |
| 82 |
23838315 |
10.1158/1078-0432.CCR-13-0955 |
2014 |
Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy. |
HLA-A |
| 83 |
24140162 |
10.1016/j.imlet.2013.09.011 |
2014 |
Standard therapies versus novel therapies in Hodgkin lymphoma. |
HLA-A |
| 84 |
24389072 |
10.1016/j.imlet.2013.12.016 |
2014 |
Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. |
HLA-A |
| 85 |
24418552 |
10.1016/j.virol.2013.11.022 |
2014 |
HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics. |
HLA-A |
| 86 |
24448864 |
10.4067/S0034-98872013000800014 |
2014 |
[Allogenic hematopoietic stem cell transplantation with unrelated cord blood: report of three cases from the Chilean cord blood bank]. |
HLA-A |
| 87 |
24461002 |
10.1111/tan.12147 |
2014 |
Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation. |
HLA-A |
| 88 |
24589652 |
10.3892/ijo.2014.2318 |
2014 |
The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers. |
HLA-A |
| 89 |
24824351 |
10.1111/bjh.12943 |
2014 |
Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma. |
HLA-A |
| 90 |
25161269 |
10.1182/blood-2014-05-576041 |
2014 |
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. |
HLA-A |
| 91 |
22343674 |
10.1038/bmt.2012.8 |
2013 |
Improved survival in matched unrelated donor transplant for childhood ALL since the introduction of high-resolution matching at HLA class I and II. |
HLA-A |
| 92 |
22406037 |
10.1016/j.bbmt.2012.01.007 |
2013 |
Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. |
HLA-A |
| 93 |
22594959 |
10.3109/09273948.2012.689074 |
2013 |
Birdshot retinochoroidopathy masquerading as intraocular lymphoma. |
HLA-A |
| 94 |
22759852 |
|
2013 |
On the aetiology of Hodgkin lymphoma. |
HLA-A |
| 95 |
22781790 |
|
2013 |
[The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation]. |
HLA-A |
| 96 |
22808081 |
10.1371/journal.pone.0039986 |
2013 |
HLA associations in classical Hodgkin lymphoma: EBV status matters. |
HLA-A |
| 97 |
22868506 |
10.1159/000338480 |
2013 |
Human leukocyte antigen (HLA)-DRB1*14 is associated with a high incidence of acute lymphocytic leukemia. |
HLA-A |
| 98 |
23143746 |
10.1007/s00262-012-1366-6 |
2013 |
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy. |
HLA-A |
| 99 |
23178241 |
10.1016/j.gene.2012.10.090 |
2013 |
Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia. |
HLA-A |
| 100 |
23269992 |
10.1200/JCO.2012.43.6832 |
2013 |
Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission. |
HLA-A |
Datasets
Models
